| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 00:22:08 UTC |
|---|
| Update Date | 2021-09-26 22:57:00 UTC |
|---|
| HMDB ID | HMDB0247362 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 3beta,7-Dihydroxyandrosta-5-ene-17-one |
|---|
| Description | 3beta,7-Dihydroxyandrosta-5-ene-17-one belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. Based on a literature review very few articles have been published on 3beta,7-Dihydroxyandrosta-5-ene-17-one. This compound has been identified in human blood as reported by (PMID: 31557052 ). 3beta,7-dihydroxyandrosta-5-ene-17-one is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 3beta,7-Dihydroxyandrosta-5-ene-17-one is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC12CCC3C(C1CCC2=O)C(O)C=C1CC(O)CCC31C InChI=1S/C19H28O3/c1-18-7-5-12(20)9-11(18)10-15(21)17-13-3-4-16(22)19(13,2)8-6-14(17)18/h10,12-15,17,20-21H,3-9H2,1-2H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 3b,7-Dihydroxyandrosta-5-ene-17-one | Generator | | 3Β,7-dihydroxyandrosta-5-ene-17-one | Generator |
|
|---|
| Chemical Formula | C19H28O3 |
|---|
| Average Molecular Weight | 304.43 |
|---|
| Monoisotopic Molecular Weight | 304.203844762 |
|---|
| IUPAC Name | 5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-one |
|---|
| Traditional Name | 5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC12CCC3C(C1CCC2=O)C(O)C=C1CC(O)CCC31C |
|---|
| InChI Identifier | InChI=1S/C19H28O3/c1-18-7-5-12(20)9-11(18)10-15(21)17-13-3-4-16(22)19(13,2)8-6-14(17)18/h10,12-15,17,20-21H,3-9H2,1-2H3 |
|---|
| InChI Key | OLPSAOWBSPXZEA-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Androstane steroids |
|---|
| Direct Parent | Androgens and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Androgen-skeleton
- 3-hydroxy-delta-5-steroid
- 3-hydroxysteroid
- 7-hydroxysteroid
- Oxosteroid
- 17-oxosteroid
- Hydroxysteroid
- Delta-5-steroid
- Cyclic alcohol
- Secondary alcohol
- Ketone
- Organic oxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Alcohol
- Organooxygen compound
- Organic oxide
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 11.9027 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.35 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2365.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 225.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 173.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 170.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 274.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 464.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 494.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 119.0 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 985.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 409.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1294.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 291.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 365.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 385.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 340.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 41.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 3beta,7-Dihydroxyandrosta-5-ene-17-one,3TMS,isomer #1 | CC12CCC(O[Si](C)(C)C)CC1=CC(O[Si](C)(C)C)C1C2CCC2(C)C(O[Si](C)(C)C)=CCC12 | 2764.3 | Semi standard non polar | 33892256 | | 3beta,7-Dihydroxyandrosta-5-ene-17-one,3TMS,isomer #1 | CC12CCC(O[Si](C)(C)C)CC1=CC(O[Si](C)(C)C)C1C2CCC2(C)C(O[Si](C)(C)C)=CCC12 | 2673.0 | Standard non polar | 33892256 | | 3beta,7-Dihydroxyandrosta-5-ene-17-one,3TMS,isomer #1 | CC12CCC(O[Si](C)(C)C)CC1=CC(O[Si](C)(C)C)C1C2CCC2(C)C(O[Si](C)(C)C)=CCC12 | 3017.0 | Standard polar | 33892256 | | 3beta,7-Dihydroxyandrosta-5-ene-17-one,3TBDMS,isomer #1 | CC12CCC(O[Si](C)(C)C(C)(C)C)CC1=CC(O[Si](C)(C)C(C)(C)C)C1C2CCC2(C)C(O[Si](C)(C)C(C)(C)C)=CCC12 | 3482.4 | Semi standard non polar | 33892256 | | 3beta,7-Dihydroxyandrosta-5-ene-17-one,3TBDMS,isomer #1 | CC12CCC(O[Si](C)(C)C(C)(C)C)CC1=CC(O[Si](C)(C)C(C)(C)C)C1C2CCC2(C)C(O[Si](C)(C)C(C)(C)C)=CCC12 | 3097.5 | Standard non polar | 33892256 | | 3beta,7-Dihydroxyandrosta-5-ene-17-one,3TBDMS,isomer #1 | CC12CCC(O[Si](C)(C)C(C)(C)C)CC1=CC(O[Si](C)(C)C(C)(C)C)C1C2CCC2(C)C(O[Si](C)(C)C(C)(C)C)=CCC12 | 3315.8 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (Non-derivatized) - 70eV, Positive | splash10-03g0-0390000000-12ffebd94bc25c94018b | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one 10V, Positive-QTOF | splash10-05n0-0093000000-57fb40fd00df41500ee1 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one 20V, Positive-QTOF | splash10-014i-2790000000-14274f7a37f5846d52d2 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one 40V, Positive-QTOF | splash10-00b9-3910000000-2b5ac1acdedd450c82f0 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one 10V, Negative-QTOF | splash10-0udi-0019000000-a0db1ea08ae4cff4cbb4 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one 20V, Negative-QTOF | splash10-0udi-0039000000-69e7e6d846905c9870dc | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,7-Dihydroxyandrosta-5-ene-17-one 40V, Negative-QTOF | splash10-0udi-0397000000-740afc2d72da2f1e5386 | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|